Jefferies Adjusts Price Target on Moderna to $180 From $155, Keeps Buy Rating

MT NewswiresJun 7 18:27

Wedbush Adjusts Price Target on Biogen to $215 From $219

MT NewswiresJun 6 19:10

Biogen Analyst Ratings

BenzingaJun 5 22:34

Regeneron Pharmaceuticals Analyst Ratings

BenzingaJun 4 21:50

RBC Capital Reiterates Sector Perform on Vertex Pharmaceuticals, Maintains $424 Price Target

BenzingaJun 4 21:50

Vertex Pharmaceuticals Analyst Ratings

BenzingaJun 4 21:48

Moderna Analyst Ratings

BenzingaJun 4 01:37

RBC Capital Maintains Outperform on Moderna, Raises Price Target to $160

BenzingaJun 4 01:39

Needham: Reiterates that Moderna (MRNA.US) holds the rating.

Zhitong FinanceJun 3 17:40

Moderna Analyst Ratings

BenzingaJun 3 17:33

Moderna: Royal Bank of Canada raised the target price from $135 to $160

Zhitong FinanceJun 3 14:40

RBC Raises Moderna's Price Target to $160 From $135

MT NewswiresJun 1 02:46

BMO Capital Maintains Outperform on Vertex Pharmaceuticals, Raises Price Target to $500

BenzingaMay 31 21:42

Vertex Pharmaceuticals Analyst Ratings

BenzingaMay 31 21:41

Analysts Offer Insights on Healthcare Companies: Veeva Systems (VEEV), Gilead Sciences (GILD) and Sanofi (OtherSNYNF)

TipRanksMay 31 17:50

Hold Rating on Gilead Sciences Amid Trodelvy Trial Setbacks and Future Uncertainties

TipRanksMay 31 17:46

Analysts' Opinions Are Mixed on These Healthcare Stocks: Gilead Sciences (GILD), Biogen (BIIB) and Argenx Se (ARGX)

TipRanksMay 31 11:00

AstraZeneca Analyst Ratings

BenzingaMay 31 02:00

European pharmaceutical giant praised by Goldman Sachs: innovation is king, and three shares received a “buy” rating

Zhitong FinanceMay 30 19:10

AstraZeneca Analyst Ratings

BenzingaMay 30 18:44